The IMF’s Understanding series of cancer information booklets is designed to acquaint you with specific multiple myeloma-related tests, treatments and therapies, supportive care measures, and common adverse events.
February 26, 2024
This publication discusses the use of DARZALEX (daratumumab) injection and DARZALEX FASPRO —for the treatment of myeloma.
October 14, 2024
This booklet discusses dexamethasone, a synthetic steroid that is one of the most frequently used medications in the treatment of myeloma.
April 05, 2024
Elrexfio™ (elranatamab-bcmm) is a B-cell maturation antigen (BCMA)-directed CD3 T-cell engager.
October 16, 2023
This publication discusses the use of Empliciti (elotuzumab)—a monoclonal antibody—for the treatment of myeloma.
December 05, 2024
Patients with myeloma may experience fatigue caused by the disease itself or by treatment for myeloma, as well as by other medical problems or their…
with support from:
Johnson & Johnson and Pfizer.